Seer (NASDAQ:SEER - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.03), Zacks reports. The company had revenue of $4.00 million for the quarter, compared to analyst estimates of $3.95 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. Seer updated its FY 2025 guidance to EPS.
Seer Stock Down 1.9 %
Shares of NASDAQ SEER traded down $0.04 during trading hours on Monday, hitting $2.06. The company had a trading volume of 429,079 shares, compared to its average volume of 213,142. The stock has a market capitalization of $121.47 million, a P/E ratio of -1.58 and a beta of 1.58. Seer has a 1-year low of $1.56 and a 1-year high of $2.63. The firm's 50 day moving average is $2.31 and its 200-day moving average is $2.12.
Seer Company Profile
(
Get Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Read More

Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.